TABLE 2.
Gene segment | Amino acid at CDR3 positiona:
|
||||||||
---|---|---|---|---|---|---|---|---|---|
95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | |
O9 cell line pool | T | P | S | G | G | Y | N | E | Q |
O9 cell lines | |||||||||
A 14/30 | T | P | S | G | G | Y | N | E | Q |
B 4/30 | S | S | A | G | G | Y | N | E | Q |
C 3/30 | S | L | S | G | A | Y | N | E | Q |
D 1/30 | S | L | S | G | G | Y | N | E | Q |
E 1/30 | S | L | S | G | G | Y | N | E | Q |
F 1/30 | S | F | A | G | G | Y | N | E | Q |
G 1/30 | S | F | S | G | G | Y | N | E | Q |
H 1/30 | T | P | G | G | G | Y | N | E | Q |
I 1/30 | N | L | A | G | G | Y | N | E | Q |
J 1/30 | S | L | A | G | G | F | T | E | A |
K 1/30 | T | F | S | G | A | Y | N | E | Q |
L 1/30 | S | S | G | G | G | Y | N | E | Q |
O9 clone 1 | S | S | G | G | G | Y | N | E | Q |
O9 clone 2 | T | L | G | G | A | Y | N | E | Q |
O22 clone 1 | S | S | A | G | G | Y | N | E | Q |
O22 clone 2 | S | S | A | G | G | Y | N | E | Q |
O22 clone 3 | S | S | A | G | G | Y | N | E | Q |
O22 clone 4 | S | S | A | G | G | Y | N | E | Q |
O22 clone 5 | S | S | A | G | G | Y | N | E | Q |
O22 clone 6 | S | S | A | G | G | Y | N | E | Q |
O22 clone 7 | S | S | A | G | G | Y | N | E | Q |
RV1 cell line pool | S | S | A | G | G | Y | N | E | Q |
For the O9 cell line, both a pool sequence and molecular clones were obtained. Letters in bold indicate amino acids that are probably contributed by the BV5.1 gene segment, and underlining indicates amino acids that are probably contributed by the BJ2.1 gene segment. The TCR beta CDR3 loop is predicted to span amino acids 95 to 106, with a framework cysteine at position 92.